 |
May 27, 2009
Arno Therapeutics Announces Three Poster Presentations at ASCO Annual Meeting more »
May 11, 2009
FDA Accepts Arno Therapeutics' IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway more »
May 4, 2009
Arno Therapeutics to Deregister its Common Stock under the Exchange Act more »
|
 |
|
